ArticleJournal of Taibah University Medical Sciences2026
Cardiometabolic diseases and prescription patterns in a Kuwait tertiary-care hospital: A retrospective cross-sectional chart review.
Article in Journal of Taibah University Medical Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tertiary-care data can provide critical insights into clinical demographics in Gulf Arab settings where these data remain limited, despite reflecting hospital-based frequencies rather than population-level prevalence. This study aimed to descriptively characterize cardiometabolic disease and medication frequencies in a tertiary-care cohort. Methods: This retrospective cross-sectional chart review included adult patients with ≥1 ICD-10-coded chronic cardiometabolic condition at Mubarak Hospital, Kuwait, between January 1, 2022, and December 31, 2024. Disease and medication frequencies were summarized by age group (<35 years, 35 to < 65 years, and ≥65 years) and sex. Univariate and multivariate associations were evaluated. Binomial regression models estimated adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs), adjusting for age or sex, nationality, and smoking status, with further adjustment for ischemic heart disease (IHD) in selected models. Results: Among 501 patients (54.1% female; mean age 63.7 ± 14.6 years), the most frequent conditions were hypertension (77.8%), diabetes mellitus (58.5%), dyslipidemia (44.7%), and IHD (23.6%). Lipid-lowering medications (76.05%) and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (59.5%) were the most common medications. Disease frequencies increased significantly with age. Compared with those aged 35 to <65 years, patients aged ≥65 years had higher adjusted prevalences of type 2 diabetes (aPR: 1.17, 95% CI: 1.00-1.35), hypertension (aPR: 1.18, 95% CI: 1.07-1.30), and IHD (aPR: 2.37, 95% CI: 1.68-3.35). Males had a significantly higher adjusted prevalence of chronic kidney disease (aPR: 1.96, 95% CI: 1.20-3.19) and IHD (aPR: 1.69, 95% CI: 1.22-2.32) than females. Notably, the higher prevalence of aspirin/clopidogrel antiplatelet therapy in males (aPR: 1.37, 95% CI: 1.11-1.69) persisted even after further adjustment for IHD (aPR: 1.30, 95% CI: 1.05-1.60). Conclusion: Within this selected cohort, the cardiometabolic burden was high and varied by age and sex. Multicenter Gulf studies with patient-level adjustment are needed to characterize the disease burden and prescribing frequencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.